北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第三临床医学院  > 血液内科  > 期刊论文
学科主题: 临床医学
题名:
Efficacy and Safety of Micafungin as Prophylaxis for Invasive Fungal Disease in Neutropenic Patients with Hematologic Malignancies
作者: Wan, Liping1; Wang, Chun1; Liu, Lin2; Tang, Xiaoqiong2; Wang, Jinghua3; Guan, Yue3; Jiang, Ming4; Duan, Xianlin4; Ke, Xiaoyan5; Jing, Hongmei5; Hu, Jiong6; Wang, Ling6; Li, Yuming7; Geng, Li7
关键词: Micafungin ; invasive fungal disease ; neutropenia ; hematologic malignancy ; prophylaxis
刊名: INTERNATIONAL JOURNAL OF PHARMACOLOGY
发表日期: 2014-05-15
DOI: 10.3923/ijp.2014.231.236
卷: 10, 期:4, 页:231-236
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Pharmacology & Pharmacy
研究领域[WOS]: Pharmacology & Pharmacy
关键词[WOS]: STEM-CELL TRANSPLANTATION ; ANTIFUNGAL PROPHYLAXIS ; INFECTIONS ; EPIDEMIOLOGY ; FLUCONAZOLE ; REGIMENS
英文摘要:

Invasive Fungal Disease (IFD) is a major cause of death in severe neutropenic patients with hematologic malignancies. Micafungin, a new echinocandin antifungal drug, is effective in treating IFD. However, the efficacy and safety of micafungin in preventing IFD in severe neutropenic patients with hematologic malignancies have not been demonstrated. A prospective and multicenter clinical study was conducted to evaluate the efficacy and safety of micafungin as prophylaxis for IFD. Micafungin 50 mg daily was administered intravenously to 117 high-risk patients with hematologic malignancies undergoing intensive chemotherapy or Hematopoietic Stem Cell Transplantation (HSCT), for a median of 24 days. Successful prophylaxis (no proven, probable or possible IFD up to 1 week after the end of prophylactic treatment) was achieved in 88.54% patients. No patient developed proven IFD during treatment and only 2.08% had probable IFD and 9.38% possible IFD. Micafungin potentially accounted for adverse events in 6.84% of patients. No severe adverse events attributable to micafungin were seen. Micafungin 50 mg daily is a promising prophylactic antifungal therapy for neutropenic patients with hematologic malignancies.

语种: 英语
WOS记录号: WOS:000343950200006
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/61796
Appears in Collections:北京大学第三临床医学院_血液内科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Tianjin First Cent Hosp, Dept Hematol, Tianjin, Peoples R China
2.Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Hematol, Shanghai 200080, Peoples R China
3.Chongqing Med Univ, Affiliated Hosp 1, Dept Hematol, Chongqing, Peoples R China
4.Harbin Med Univ, Affiliated Hosp 2, Dept Hematol, Harbin, Peoples R China
5.Xinjiang Med Univ, Hematol Dis Ctr, Affiliated Hosp 1, Xinjiang, Peoples R China
6.Beijing Med Univ, Dept Hematol, Affiliated Hosp 3, Beijing 100083, Peoples R China
7.Shanghai Jiao Tong Univ, Affiliated Ruijin Hosp, Dept Hematol, Shanghai 200080, Peoples R China

Recommended Citation:
Wan, Liping,Wang, Chun,Liu, Lin,et al. Efficacy and Safety of Micafungin as Prophylaxis for Invasive Fungal Disease in Neutropenic Patients with Hematologic Malignancies[J]. INTERNATIONAL JOURNAL OF PHARMACOLOGY,2014,10(4):231-236.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Wan, Liping]'s Articles
[Wang, Chun]'s Articles
[Liu, Lin]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Wan, Liping]‘s Articles
[Wang, Chun]‘s Articles
[Liu, Lin]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace